NIPT (Non-Invasive Prenatal Screening Test) Screening Tests in Milton Keynes - Private illumina Tests

Harness the power of illumina/NIPT Testing at Milton Keynes Numi Scan, where we analyse foetal DNA fragments present in maternal blood to predict the risk of Down syndrome (Trisomy 21) and other specific genetic conditions. Our illumina Prenatal Test not only offers enhanced accuracy but also provides optional foetal sex assessment at no additional charge. It's imperative to note that while NIPT testing excels in detecting chromosomal anomalies, it does not screen for non-chromosomal disorders, familial mutations, or foetal viability.

Ideally accessible to women with pregnancies of at least a 10-week gestation period, NIPT Screening at Milton Keynes Numi Scan caters to both single and twin pregnancies, regardless of conception method. However, it's essential to understand that NIPT may not be suitable for cases involving certain complexities, such as a vanishing twin. Our comprehensive testing ensures peace of mind for expectant mothers and facilitates informed decision-making throughout pregnancy.

With us, obtaining accurate Trisomy 21 screening is as easy as:=

1. Early Pregnancy Scan
2. Blood Test
3. Receive Results in 2-5 Working Days (once the lab receives the blood sample)

NIPT testing at Milton Keynes Numi Scan primarily screens for the risk of the three major syndromes:

• Trisomy 21 (Down syndrome)
• Trisomy 18 (Edward syndrome)
• Trisomy 13 (Patau syndrome)

The NIPT test isn't meant for detecting physical abnormalities like heart or brain issues, spina bifida, or concerns about foetal growth. For a thorough foetal anatomy evaluation, it's recommended to pair the NIPT test with NHS ultrasound scans at 11-13 and 20-22 weeks, and at 30-32 weeks if needed for growth assessment.

The VeriSeq NIPT Solution V2 isn't verified for pregnancies with more than two foetuses, foetal demise, mosaicism, partial chromosome aneuploidy, triploidy, translocations, maternal aneuploidy, transplant, malignancy, or neural tube defects. Rare biological conditions could affect the test's accuracy.

Importantly, a low probability outcome doesn't ensure the absence of chromosomal or genetic conditions in the foetus. Some non-aneuploid foetuses might yield high-probability results. Confirmatory testing is vital for diagnoses when high probability results or other clinical signs of a chromosomal condition are present.

In short, while NIPT excels in chromosomal anomaly detection, it does not identify physical abnormalities or certain genetic conditions. For comprehensive foetal anatomy assessment, complement NIPT testing with NHS ultrasound scans at recommended intervals.